UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000011336
Receipt No. R000013187
Official scientific title of the study Effect of add-on medication (with dose increase, combined with anti-leukotriene , combined with steroid nasal spray)for allergic rhinitis patients who are not effective of normal dose of Bepotastine besilate .
Date of disclosure of the study information 2013/10/01
Last modified on 2016/08/04 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effect of add-on medication (with dose increase, combined with anti-leukotriene ,
combined with steroid nasal spray)for allergic rhinitis patients who are not effective of normal dose of Bepotastine besilate .
Title of the study (Brief title) Effect of add-on medication (with dose increase, combined with anti-leukotriene ,
combined with steroid nasal spray)for allergic rhinitis patients who are not effective of normal dose of Bepotastine besilate .
Region
Japan

Condition
Condition allergic rhinitis
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Examination of the effect of add-on medication (with dose increase,combined with anti-leukotriene,combined with steroid nasal spray) for allergic patients
.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Phase II

Assessment
Primary outcomes Assesment of symptom after as below for the allergic rhinitis patients .

Allergic rhinitis patients are separeted 3groups(dose increase,combined with anti-luekotriene, combined with steroid nasal spray) ,and carry on for 4 week.
Assesment:medical examination at the department of otorhinolaryngology with a disease questionnaire.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Randomized
Randomization unit Individual
Blinding Single blind -participants are blinded
Control Dose comparison
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Numbered container method

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 1Double dose , 2used together with anti leuotorien,3used together with steroid nasal spray
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
16 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria allergoc rhinitis
Key exclusion criteria Patients judged inappropriate for this study by the physicians
Target sample size 150

Research contact person
Name of lead principal investigator Nibu Keni-chi
Organization Kobe University Graduate Scool of Medicine
Division name Department of otorhinolaryngology Head and Neck Surgery
Address 7-5-1,Kusunoki-cho,Chuo-ku,Kobe,Hyogo,650-0017,Japan
TEL 81-78-382-5111
Email nibu@med.kobe-u.ac.jp

Public contact
Name of contact person Nibu Keni-chi
Organization Kobe University Graduate Scool of Medicine
Division name Department of otorhinolaryngology Head and Neck Surgery
Address 7-5-1,Kusunoki-cho,Chuo-ku,Kobe,Hyogo,650-0017,Japan
TEL 81-78-382-5111
Homepage URL http://www.hosp.kobe-u.ac.jp/chiken/OOchiken_top.htm
Email nibu@med.kobe-u.ac.jp

Sponsor
Institute Graduate Scool of Medicine
Institute
Department

Funding Source
Organization Graduate Scool of Medicine Department of otorhinolaryngology Head and Neck Surgery
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 10 Month 01 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2013 Year 07 Month 22 Day
Anticipated trial start date
2013 Year 09 Month 18 Day
Last follow-up date
2014 Year 07 Month 31 Day
Date of closure to data entry
2014 Year 07 Month 31 Day
Date trial data considered complete
2014 Year 07 Month 31 Day
Date analysis concluded
2014 Year 07 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2013 Year 07 Month 31 Day
Last modified on
2016 Year 08 Month 04 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000013187